One of the most consequential decisions in any home care agency sale is also one of the least understood: should you sell to a strategic acquirer or a private equity-backed platform?
The answer isn’t obvious. Strategic buyers and PE firms have fundamentally different motivations, price differently, operate differently post-close, and will treat your employees and culture differently. Getting this decision right can mean millions of dollars in outcome — and months or years of post-close satisfaction or regret.
This guide breaks down both buyer types, when each makes sense, and how to structure your process to get the best outcome regardless of which path you choose.
A strategic buyer is an operating company that acquires to expand its existing business. In home-based care, strategic acquirers include:
Strategic buyers pay for operational synergies — they expect to reduce costs, expand revenue, and leverage your accounts, licenses, and geography within their existing infrastructure. Their model assumes you become part of them.
A private equity buyer is a financial sponsor — typically a PE firm or PE-backed platform — that acquires to grow and eventually resell the business, usually within 3–7 years. In home care, PE buyers include:
PE buyers do not plan to operate your business forever. They are building for a future sale or recapitalization. Their model assumes the agency continues to operate relatively independently — at least initially — while they inject capital, infrastructure, and management support to accelerate growth.
| Factor | Strategic Buyer | Private Equity |
|---|---|---|
| Typical multiple | Moderate — pays on synergies | Higher — pays on standalone cash flow |
| Process speed | Slower — requires board approval | Faster — partners have more authority |
| Post-close independence | Low — expect integration | Higher — often retain brand and operations |
| Your role post-close | Typically 6–24 months transition | 2–5 year earnout/run-role common |
| Employee retention risk | High — redundant roles eliminated | Lower — culture often preserved |
| Rollover equity opportunity | Rare | Common — often expected |
| Cultural fit | Absorbed into corporate culture | More entrepreneurial, growth-focused |
| Brand retention | Usually eliminated | Often retained, especially early |
The conventional wisdom is that “PE pays more.” This is often true — but not always. Strategic buyers can and do pay premium prices in specific circumstances:
Geography is a key unlock. If your agency operates in a market where a strategic buyer has zero presence, your licenses, referral relationships, and accreditations represent the fastest (and cheapest) path to market entry. In this scenario, the strategic buyer may pay above-market multiples because the alternative — starting from scratch — is far more expensive.
Your payer mix complements theirs. A Medicare-certified home health agency being acquired by a hospice company seeking to add home health services may command a premium because the buyer values the complement to its existing revenue base.
Scale creates negotiating leverage. Large agencies ($3M+ EBITDA) attract multiple strategic buyers, which creates competitive tension. Competition — not buyer type — is the primary driver of price.
PE buyers typically lead on price for several reasons:
They value standalone cash flow, not synergies. PE firms price based on your normalized EBITDA multiplied by a market multiple. They are not assuming cost cuts or revenue tricks — they are buying the cash flow as-is. This is often more favorable to sellers than synergy-based pricing.
They have flexible capital structures. PE firms can structure deals with seller rollover equity, earnouts, and creative deal structures that increase total potential value. A deal that looks smaller on day one can produce significantly more total proceeds if the platform is eventually sold at a higher multiple.
Rollover equity is a real asset. Many PE-backed platforms offer sellers the opportunity to roll 10–30% of their sale proceeds into equity in the platform. If the platform exits in 5 years at a higher multiple, that rolled equity can produce a second liquidity event that exceeds the initial sale proceeds.
The most financially sophisticated home care exits of the past decade have involved rollover equity — selling 70–80% of the business now and keeping 20–30% equity in the PE-backed platform.
Here is a simplified example:
You sell your agency for $10M in total enterprise value. You take $7.5M in cash at close and roll $2.5M into the platform.
The PE firm grows the platform from $5M EBITDA to $12M EBITDA over 5 years and sells it at 8× EBITDA = $96M.
Your 5% equity stake (representing your $2.5M roll on a $50M platform) is worth $4.8M at exit.
Total proceeds: $7.5M + $4.8M = $12.3M — 23% more than a clean cash sale.
Of course, rollover equity carries real risk. The platform may fail to grow. The next buyer may offer lower multiples. Management may change. Every rollover decision requires careful legal review and realistic assessment of the sponsoring PE firm’s track record.
Both strategic and PE buyers sometimes offer earnouts — additional purchase price paid if the business hits certain performance targets post-close.
Earnouts are often presented as a way to bridge a valuation gap. But sellers should approach them with extreme caution:
A strong M&A process typically minimizes the need for earnouts by creating enough competition that buyers offer clean, full-value upfront pricing.
Ask yourself these five questions:
1. How important is your brand and legacy? If you’ve built a 20-year business and the name means something to your community and employees, a PE buyer who retains your brand and management team will feel very different from a strategic buyer who repaints your vehicles and re-badges your staff within 90 days.
2. Do you want to keep working — and in what capacity? Strategic buyers often want you gone in 12–24 months. PE buyers frequently want you to keep running the business and accelerate growth. If you love what you do and want to stay involved, PE is often a better fit.
3. How much risk are you willing to take on rollover equity? Rollover equity can double your total outcome — or disappear. It requires a thesis about the PE firm, the platform, and the market. If you need certainty, take more cash upfront.
4. What’s your timeline? If you need to close in 6 months for personal reasons, a PE buyer’s faster process may be preferable. Strategic buyers’ boards move slowly.
5. What do your key employees need? In a strategic acquisition, overlapping back-office functions are typically eliminated. In PE, growth-mode acquisitions often expand the team. Consider the people who’ve built the business with you.
The most reliable way to maximize your outcome is not to pre-select a buyer type — it’s to run a competitive process that includes all qualified buyer types and let the market tell you who values your business most and under what terms.
This is precisely what a specialized M&A advisor does: they know every active buyer in home-based care, understand each buyer’s current acquisition criteria, and can position your agency to five, ten, or twenty buyers simultaneously — creating genuine competition.
Competition is what produces premium pricing. Without it, you are negotiating alone against a buyer who has done this hundreds of times.
Contact Hendon Partners to discuss your exit options →
Hendon Partners is a sell-side M&A advisory firm exclusively focused on home-based care. We do not represent buyers. Every engagement is structured to maximize seller outcomes.
Newsletter
Receive new articles, EBITDA benchmark updates, and deal intelligence directly in your inbox. No spam — unsubscribe anytime.
Join 1,200+ home care executives. Unsubscribe anytime.
